AMGN Stock — Amgen Inc.

Amgen Inc. (AMGN)

Updated October 16, 2026.

AMGN is a Stock. its distribution rate is 2.33%, its trailing-12-month yield is 2.30%. Dividend Vision Distribution Safety Score™ is 100/100 (Safe). Total return is 188348.8% over the past 43.3 years.

Amgen is a multinational biotechnology company that discovers, develops, manufactures, and distributes human therapeutics with a focus on inflammation, oncology, bone health, and cardiovascular diseases. The company maintains a modest current distribution rate and pays dividends quarterly. Amgen appeals to income-focused investors seeking exposure to the large-cap pharmaceutical and biotech sector.

AMGN performance

Price and return data through 2026-10-16.

Total return is 188348.8% over the past 43.3 years. Over the past year its total return — price change plus distributions reinvested — is 50.3%. Its deepest 1-year drawdown was 16.6%.

AMGN key facts

Distribution Safety Score™

100 · Safe

Safety-Adjusted Yield

2.33%

Asset type

Stock

Asset class

Equity

Inception date

06/17/1983

Distribution rate

2.33%

Distribution frequency

Quarterly

Trailing yield

2.30%

5-year average yield

3.0

Last close

$432.49 (as of 2026-10-16)

Market cap

$233,817,935,842

Average volume

2567100.0

Dividend

$2.52

Ex-dividend date

08/21/2026

Payment date

09/11/2026

Beta

0.407

Payout ratio

44.4%

P/E ratio

26.86

Forward P/E

16.6667

EPS

$16.10

How Dividend Vision calculates yield and returns

Distribution rate (2.33%) uses calculation basis unavailable. Issuer rates can use a different denominator and date, including ex-date NAV. Trailing-12-month yield (2.30%) is the sum of split-adjusted cash distributions with ex-dates in the last 12 months, divided by the published price. It lags a recent raise or cut. Total return uses split-adjusted close with distributions reinvested on the ex-dividend date (a modeling convention, not the cash-settlement date) from the first stored bar on or after inception through the latest bar, compared with the same window on the benchmark. That is the security's total return, not your personal gain/loss.

Yield and safety methodology · Distribution rate methodology · Distribution Safety Score methodology

Sources and review

Primary sources: prices and distributions from Dividend Vision, derived from vendor EOD data.

Reviewed by Bert Sweet, CEO and Co-owner of Dividend Vision. Methodology: Distribution Safety Score.

AMGN risks and drawbacks

AMGN's current distribution rate is moderate, not a high-yield payout — the strategy is dividend quality more than maximum income. Payments are quarterly, so cash flow is lumpy versus a monthly fund. The deepest 1-year drawdown on record here is 16.6%.

Who may consider AMGN — and who may not

AMGN may suit someone looking for a high Distribution Safety Score, moderate current income with a quality tilt. It is a weaker fit for investors who need monthly cash flow (AMGN pays quarterly); investors hunting double-digit covered-call yields. This is educational context, not a recommendation to buy or sell.

More on AMGN

• ETFs holding AMGN
• All tickers starting with A

Tagged: Dividend, Pharmaceutical.

Frequently asked questions